Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study

Schadendorf, D.; Amonkar, M. M.; Milhem, M.; Grotzinger, K.; Demidov, L. V.; Rutkowski, P.; Garbe, C.; Dummer, R.; Hassel, J. C.; Wolter, P.; Mohr, P.; Trefzer, U.; Lefeuvre-Plesse, C.; Rutten, A.; Steven, N.; Ullenhag, G.; Sherman, L.; Wu, F. S.; Patel, K.; Casey, M.; Robert, C.

dc.contributor.author	Garbe, Claus
dc.date.accessioned	2014-08-05T08:07:37Z
dc.date.available	2014-08-05T08:07:37Z
dc.date.issued	2014
dc.identifier.issn	0923-7534
dc.identifier.uri	http://hdl.handle.net/10900/55166
dc.language.iso	en	en
dc.publisher	Oxford Univ Press	de_DE
dc.relation.uri	http://dx.doi.org/10.1093/annonc/mdt580	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study	de_DE
dc.type	Article	de_DE
utue.quellen.id	20140610213910_00589	de_DE
utue.publikation.seiten	700-706	de_DE
utue.personen.roh	Schadendorf, D.
utue.personen.roh	Amonkar, M. M.
utue.personen.roh	Milhem, M.
utue.personen.roh	Grotzinger, K.
utue.personen.roh	Demidov, L. V.
utue.personen.roh	Rutkowski, P.
utue.personen.roh	Garbe, C.
utue.personen.roh	Dummer, R.
utue.personen.roh	Hassel, J. C.
utue.personen.roh	Wolter, P.
utue.personen.roh	Mohr, P.
utue.personen.roh	Trefzer, U.
utue.personen.roh	Lefeuvre-Plesse, C.
utue.personen.roh	Rutten, A.
utue.personen.roh	Steven, N.
utue.personen.roh	Ullenhag, G.
utue.personen.roh	Sherman, L.
utue.personen.roh	Wu, F. S.
utue.personen.roh	Patel, K.
utue.personen.roh	Casey, M.
utue.personen.roh	Robert, C.
dcterms.isPartOf.ZSTitelID	Annals of Oncology	de_DE
dcterms.isPartOf.ZS-Issue	3	de_DE
dcterms.isPartOf.ZS-Volume	25	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE